Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fibrosis × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 4 Polycythemia Vera 3 Venous Thromboembolism 2 Thrombocythemia, Essential 2 Rectal Neoplasms 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Cardiovascular Diseases 2 Adenoma 2 Vascular Diseases 1 Thrombosis 1 Thrombocytopenia 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Pathologic Processes 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Ischemic Stroke 1

Interventions

esmolol 1 epigallocatechin gallate 1 contrast agent BR1 1 alpha-Tocopherol 1 Viusid 1 Sonazoid 1 Sodium Chloride 1 Simvastatin 1 Pentoxifylline 1 Metformin 1 Iodides 1 Everolimus 1 Dietary Supplements 1 Catechin 1 Aspirin 1 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡